Labeled for this condition
Medicines for nausea and vomiting
16 medicines have an FDA label indicated for nausea and vomiting; 13 are listed from generic labelers and 0 have a presentation in shortage now (FDA files, October 8, 2026).
Which medicines are labeled for nausea and vomiting?
Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Ondansetron | none listed | 77 labelers | $0.0582 per tablet 4 mg tablet | No | No current entry | 15 |
| Bismuth subsalicylate | none listed | none listed | $0.0817 per tablet 262 mg tablet chewable | No | No current entry | 1 |
| Meclizine | none listed | 24 labelers | $0.0442 per tablet 12.5 mg tablet | No | No current entry | 12 |
| Chlorpromazine | none listed | 33 labelers | $0.552 per tablet 100 mg tablet | Yes | No current entry | 25 |
| Prochlorperazine | Compro | 45 labelers | $0.162 per tablet 10 mg tablet | Yes | No current entry | 3 |
| Metoclopramide | Reglan, Gimoti | 39 labelers | $0.0439 per tablet 10 mg tablet | Yes | No current entry | 10 |
| Perphenazine | none listed | 16 labelers | $0.161 per tablet 4 mg tablet | Yes | No current entry | 1 |
| Dimenhydrinate | none listed | 1 labeler | $0.0575 per tablet 50 mg tablet | No | No current entry | 0 |
| Aprepitant | Emend, Aponvie, Cinvanti | 5 labelers | $46.42 per capsule 40 mg capsule | No | A presentation being discontinued | 3 |
| Scopolamine | Transderm | 11 labelers | $4.34 per patch 1 mg/3 day patch | No | A presentation being discontinued | 2 |
| Palonosetron | Posfrea | 13 labelers | n/a | No | A presentation being discontinued | 0 |
| Granisetron | Sustol, Sancuso, Granisol | 8 labelers | $1.31 per tablet 1 mg tablet | No | No current entry | 1 |
| Doxylamine and pyridoxine | Bonjesta, Diclegis | 4 labelers | $1.09 per unit 10-10 mg | No | No current entry | 2 |
| Trimethobenzamide | Tigan | 5 labelers | n/a | No | No current entry | 0 |
| Amisulpride | Barhemsys | none listed | n/a | No | No current entry | 0 |
| Tradipitant | Nereus | none listed | n/a | No | No current entry | 0 |
Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price